Sartorius Aktiengesellschaft (BIT:1SRT3)

Market Cap	11.51B
Revenue (ttm)	3.47B
Net Income (ttm)	104.10M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	110.57
Forward PE	30.58
Dividend	0.74 (0.41%)
Ex-Dividend Date	Mar 28, 2025

Volume	10
Average Volume	37
Open	178.00
Previous Close	195.30
Day's Range	178.00 - 178.55
52-Week Range	176.10 - 283.40
Beta	n/a
RSI	19.63
Earnings Date	Jul 22, 2025

About Augmedix

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Laboratory Analytical Instruments
• Founded: 1870
• Employees: 13,528
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SRT3

Financial Performance

In 2024, BIT:1SRT3's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.